Clene
NASDAQ: CLNNSalt Lake City, US · Founded 2020 · Delaware corporation
Find your way into Clene
137 people in our graph share verified history with the Clene team — schools, employers, funds. One of them is your warm intro.
Jeff Lawsonunlockedknows Robert Glanzman · together at Duke University School of Medicine (overlapped)
×4knows the team · via University of North Carolina at Charlotte
knows the team · via Duke University School of Medicine
×4knows the team · via University of Michigan Medical School
×2knows the team · via Nektar Therapeutics
Clene is a clinical-stage biopharmaceutical company developing nanotherapeutics that target cellular energy impairments to treat neurodegenerative diseases and restore neuronal health. Its platform produces clean-surfaced, catalytically-active nanocrystals for therapeutic use.
Founders & leadership
Clene was founded in 2020 by Mark Mortenson and Reed N. Wilcox.
MM
Mark MortensoninCo-founder and CSOformer
RN
Reed N. WilcoxIndependent Director
MB
Morgan BrowninChief Financial Officer
RG
Robert GlanzmaninChief Medical Officer2019–2023Robert Glanzman is a board-certified neurologist with over 25 years of experience in clinical development and medical affairs in neuroscience, and serves as Executive Officer of Clene, a clinical-stage biopharmaceutical company developing nanotherapeutics for neurodegenerative diseases.
TH
Tae Heum JeongExecutive
RE
Robert EtheringtonPresident, Chief Executive Officer, and Director
CU
Chidozie UgwumbaNamed on SEC filing
FC
Fiona CostelloNamed on SEC filing
JS
John StevensNamed on SEC filing
Board
DM
David MatlinBoard director
AM
Alison MoscaBoard director
SJ
Shalom JacobovitzBoard director
Reported raises · per SEC filings
Form D private placements$16.6M disclosed across 2 of 4 rounds · 2018–2026
▶$7.3MraisedOct 2024 · 13 investors · PharmaceuticalsRule 506(b)
▶$7.3MraisedOct 2024 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Alison MoscaDirector
- Mark MortensonExecutive Officer
- Robert Dee EtheringtonExecutive Officer, Director
- Shalom JacobovitzDirector
- Morgan BrownExecutive Officer
- David MatlinDirector
- Jonathon T. GayDirector
- Reed Neil WilcoxDirector
- Vallerie V. McLaughlinDirector
- Matthew KiernanDirector
- Arjun DesaiDirector
- Offering amount
- $7.3M
- Amount sold
- $7.3M
- Sales commissions
- $436.6K
- Placement agents
- Canaccord Genuity LLC
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$9.3MraisedMay 2021 · 8 investors · PharmaceuticalsRule 506(b)
▶$9.3MraisedMay 2021 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Alison MoscaDirector
- David MatlinDirector
- Robert GlanzmanExecutive Officer
- Tae Heum JeongExecutive Officer
- Shalom JacobovitzDirector
- Reed WilcoxDirector
- Chidozie UgwumbaDirector
- Fiona CostelloDirector
- Jonathon GayDirector
- Robert EtheringtonExecutive Officer, Director
- John StevensDirector
- Mark MortensonExecutive Officer
- Offering amount
- $9.3M
- Amount sold
- $9.3M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlap
TradingView21 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
StockTwits20 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Robinhood19 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha18 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Simply Wall St18 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Public17 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
TipRanks17 shared keywordsFinancial analysis and stock research platform.
Companies competing with Clene for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Clene (NASDAQ:CLNN): Why Is Clinical Evidence in Focus Today?kalkinemedia.com · Aug 2026Frequently asked questions
- What does Clene do?
- Clene is a clinical-stage biopharmaceutical company developing nanotherapeutics that target cellular energy impairments to treat neurodegenerative diseases and restore neuronal health. Its platform produces clean-surfaced, catalytically-active nanocrystals for therapeutic use.
- Who founded Clene?
- Clene was founded by Mark Mortenson, Reed N. Wilcox in 2020.
- How much funding has Clene raised?
- Clene has disclosed $16.6M raised across 2 of its 4 known rounds.
- Where is Clene headquartered?
- Clene is headquartered in Salt Lake City, US.